Anika to Issue Second-Quarter 2019 Financial Results and Business Highlights on Wednesday, July 24
July 10 2019 - 4:05PM
Business Wire
Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the
Company plans to issue its second-quarter 2019 financial results
after the close of the market on Wednesday, July 24, 2019 and hold
its investor conference call on the same day, Wednesday, July 24,
2019, at 5:00 p.m. ET to discuss its financial results, business
highlights, and outlook.
The conference call can be accessed by dialing 1-855-468-0611
(toll-free domestic) or 1-484-756-4332 (international). A live
audio webcast will be available in the "Investor Relations" section
of Anika's website, www.anikatherapeutics.com. An accompanying
slide presentation also can be accessed via the Anika Therapeutics
website. The call will be archived and accessible on the same
website shortly after its conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK) is a global, integrated
orthopedic and regenerative medicines company based in Bedford,
Massachusetts. Anika is committed to improving the lives of
patients with degenerative orthopedic diseases and traumatic
conditions with clinically meaningful therapies along the continuum
of care, from palliative pain management to regenerative tissue
repair. The Company has over two decades of global expertise
developing, manufacturing, and commercializing more than 20
products based on its proprietary hyaluronic acid (HA) technology.
Anika's orthopedic medicine portfolio includes ORTHOVISC®,
MONOVISC®, and CINGAL®,which alleviate pain and restore joint
function by replenishing depleted HA, and HYALOFAST, a solid
HA-based scaffold to aid cartilage repair and regeneration. For
more information about Anika, please visit
www.anikatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190710005042/en/
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer For Media Inquiries: W2O Group
Sonal Vasudev, 917-523-1418 sonal@w2ogroup.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024